News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
620,975 Results
Type
Article (47544)
Company Profile (97)
Press Release (573334)
Section
Business (174539)
Career Advice (2991)
Deals (30992)
Drug Delivery (110)
Drug Development (76818)
Employer Resources (167)
FDA (15111)
Job Trends (13963)
News (304568)
Policy (30290)
Tag
Academia (2740)
Alliances (42741)
Alzheimer's disease (1357)
Approvals (15058)
Artificial intelligence (193)
Bankruptcy (323)
Best Places to Work (11314)
Breast cancer (219)
Cancer (1613)
Cardiovascular disease (137)
Career advice (2519)
CAR-T (122)
Cell therapy (337)
Clinical research (61615)
Collaboration (593)
Compensation (207)
COVID-19 (2670)
C-suite (155)
Data (1522)
Diabetes (207)
Diagnostics (6250)
Earnings (66424)
Employer resources (148)
Events (95073)
Executive appointments (548)
FDA (15930)
Funding (547)
Gene therapy (246)
GLP-1 (683)
Government (4678)
Healthcare (18348)
Infectious disease (2776)
Inflammatory bowel disease (117)
Interviews (601)
IPO (14207)
Job creations (3059)
Job search strategy (2059)
Layoffs (448)
Legal (6566)
Lung cancer (245)
Manufacturing (225)
Medical device (12529)
Medtech (12534)
Mergers & acquisitions (17090)
Metabolic disorders (550)
Neuroscience (1774)
NextGen: Class of 2025 (6425)
Non-profit (4561)
Northern California (1791)
Obesity (308)
Opinion (232)
Parkinson's disease (116)
Patents (141)
People (53981)
Phase I (18943)
Phase II (27081)
Phase III (20732)
Pipeline (655)
Postmarket research (2458)
Preclinical (7866)
Radiopharmaceuticals (236)
Rare diseases (315)
Real estate (4881)
Regulatory (20730)
Research institute (2387)
Resumes & cover letters (471)
Southern California (1580)
Startups (3085)
United States (16232)
Vaccines (621)
Weight loss (226)
Date
Today (139)
Last 7 days (590)
Last 30 days (2723)
Last 365 days (33438)
2025 (2825)
2024 (33863)
2023 (38121)
2022 (49112)
2021 (53205)
2020 (52353)
2019 (45466)
2018 (34565)
2017 (30757)
2016 (29842)
2015 (34813)
2014 (26511)
2013 (21863)
2012 (23561)
2011 (24409)
2010 (21714)
Location
Africa (844)
Arizona (167)
Asia (37078)
Australia (7331)
California (4113)
Canada (1552)
China (354)
Colorado (203)
Connecticut (193)
Europe (83302)
Florida (616)
Georgia (150)
Illinois (424)
Indiana (238)
Maryland (700)
Massachusetts (3020)
Michigan (197)
Minnesota (307)
New Jersey (1210)
New York (1201)
North Carolina (773)
Northern California (1791)
Ohio (160)
Pennsylvania (964)
South America (1138)
Southern California (1580)
Texas (605)
Utah (130)
Washington State (416)
620,975 Results for "marken formerly known as marken time critical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Thubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study With Novel Optimum TAV™ at EuroPCR 2023
Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis will be presented at the upcoming EuroPCR 2023 Conference.
May 2, 2023
·
3 min read
Government
COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post
Makary is a pancreatic surgeon at Johns Hopkins who became known for battling medical mistakes and in recent years has been an outspoken critic of COVID-19 policies.
November 21, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Thubrikar Aortic Valve completes initial CE Mark-enabling TAVI-1 Study
Thubrikar Aortic Valve, Inc., announced today that it has completed the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis.
October 21, 2022
·
3 min read
Press Releases
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
January 7, 2025
·
1 min read
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Venture capitalists
The Megaround Ruled Biopharma in 2024 as First-Time VC Funding Doubled
Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 deals in 2023.
January 9, 2025
·
2 min read
·
Annalee Armstrong
Bio NC
Marken Opens Two New GMP Depots
Marken announced the launch of two new facilities in Kiev, Ukraine and in Los Angeles, United States.
December 22, 2020
·
2 min read
1 of 62,098
Next
